Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Labinic
- Development stage
- Phase 3
- Lead developer
- Biofloratech
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Labinic is a multi-strain liquid probiotic supplement specifically formulated for infants and children from birth onwards. It contains three clinically researched strains of live bacteria—Lactobacillus acidophilus (NCFM), Bifidobacterium bifidum (Bb-06), and Bifidobacterium infantis (Bi-26)—suspended in pharmaceutical-grade medium chain triglyceride (MCT) oil. The product is designed to support and optimize the intestinal microbiome, promote healthy gut flora, and improve feed tolerance in babies. It is vegan-friendly, free from dairy, gluten, animal products, allergens, preservatives, sweeteners or colorants. Manufactured to GMP standards with rigorous quality controls and proven safety profile in clinical use. Widely used in neonatal units and recommended by paediatricians for conditions such as dysbiosis or after antibiotic exposure[1][2][3][5][6].
- Brand names
- Labinic
- Other names
- Labinic DropsLabinic ProbioticLabinic Probiotic Drops
Beyond the preview
Go deeper on Labinic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Labinic.